10/18/2021 2:05:40 AM
AstraZeneca Recommends Shareholders Reject Mini-Tender Offer By TRC Capital
10/15/2021 2:07:54 AM
AstraZeneca Says Positive Results From HIMALAYA Phase 3 Trial In 1st-line Unresectable Liver Cancer
10/11/2021 2:04:38 AM
AstraZeneca Says TACKLE Phase III COVID-19 Treatment Trial Shows Positive Results
10/8/2021 7:05:11 AM
AstraZeneca: FDA Grants Orphan Drug Designation For Tezepelumab In The US For Eosinophilic Esophagitis
10/5/2021 2:27:42 AM
AstraZeneca Requests FDA For Emergency-use Authorization For AZD7442 For COVID-19 Prophylaxis
10/4/2021 7:06:24 AM
Compugen To Receive $6 Mln Milestone Payment From AstraZeneca
10/4/2021 2:07:57 AM
AstraZeneca: FDA Grants Breakthrough Therapy Designation For Enhertu In The US
9/29/2021 2:11:32 AM
AstraZeneca's Alexion Exercises Option To Acquire Caelum Biosciences For CAEL-101
9/28/2021 2:07:19 AM
AstraZeneca Says Saphnelo Approved In Japan For Systemic Lupus Erythematosus In Adults
9/24/2021 2:02:19 AM
AstraZeneca Says Lynparza PROpel Trial Meets Primary Endpoint